The Defeat GBM Research Collaborative is the National Brain Tumor Society’s largest and boldest strategic research initiative to date*. The initiative aims to significantly improve the survival rate of patients who are battling glioblastoma multiforme (GBM). Through robust collaborations comprised of leading GBM researchers, multiple and synergistic projects are driven by investigator teams with proven track records of collaborating and producing results.
This unique model of integrated drug discovery allows for better data sharing and knowledge transfer between the interrelated projects that comprise Defeat GBM, with the goal of moving potential new glioblastoma treatments from the lab to the clinic with greater speed and precision.
To learn more, please watch this short video from two of the leaders of the Defeat GBM Research Collaborative:
To take a deeper dive into the work of the projects within the Defeat GBM Research Collaborative, you can watch the following videos from Part 1 of our Program Insights series on Defeat GBM’s Discovery and Systems Biology efforts.
*Defeat GBM is a subsidiary of the National Brain Tumor Society.